Anúncio
Anúncio
VTVT
vTv Therapeutics Inc. Class A Common Stock
33.55
USDPatrocinado
-7.51
-18.28%
09 de jan., 14:08 UTC -5
Abrir
Relatórios de Lucros VTVT
Rácio de surpresa positiva
VTVT separação 21 de 34 últimas estimativas.
62%
Próximo Relatório
Data do Próximo Relatório
18 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$1.07
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-0.93%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-100.00%
/+94.55%
vTv Therapeutics Inc. Class A Common Stock earnings per share and revenue
On 06 de nov. de 2025, VTVT reported earnings of -1.08 USD per share (EPS) for Q3 25, missing the estimate of -0.99 USD, resulting in a -8.04% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.16% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analistas forecast an EPS of -1.07 USD, with revenue projected to reach -- USD, implying an diminuir of -0.93% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were vTv Therapeutics Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, vTv Therapeutics Inc. Class A Common Stock reported EPS of -$1.08, missing estimates by -8.04%, and revenue of $0.00, 0% as expectations.
How did the market react to vTv Therapeutics Inc. Class A Common Stock's Q3 2025 earnings?
The stock price moved up 2.16%, changed from $25.47 before the earnings release to $26.02 the day after.
When is vTv Therapeutics Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for 18 de mar. de 2026.
What are the forecasts for vTv Therapeutics Inc. Class A Common Stock's next earnings report?
Based on 5
analistas, vTv Therapeutics Inc. Class A Common Stock is expected to report EPS of -$1.07 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio